Stay updated on N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial
Sign up to get notified when there's something new on the N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial page.

Latest updates to the N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check45 days agoChange DetectedThe study page shows reorganized sections and updated styling, while the underlying content (inclusion criteria, outcomes, and contact details) remains unchanged.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded a new site revision banner 'Revision: v3.4.2'. Removed the prior funding status notice and the older 'Revision: v3.4.1' banner.SummaryDifference0.5%

- Check66 days agoChange DetectedA government funding lapse notice and status banner was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check73 days agoChange DetectedUI and metadata updates (glossary toggle, QC status wording update, and revision to v3.4.0) occurred, with the older QC wording and 'No FEAR Act data' text removed, and no changes to study content, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial page.